Archive - September 2024
Baale Emerges President, as NAPharm Honours Zulum, Inducts New Fellows
Industry Leaders Advocate Wellness, Self-Care at D’Bio Summit
What the Fed’s rate cut means for biotech
Life after University
FDA approves nasal spray influenza vaccine for self- or caregiver-administration
After epilepsy setback, Ovid charges confidently ahead in CNS
FDA Approves Miplyffa (arimoclomol) for the Treatment of Niemann-Pick Disease Type C
FluMist Approved for Self-Administration in the US